Sionna Therapeutics is trading at $4.24, up 5.61%, alongside broader biotech strength, with XBI up 2.09%.
- On October 20, 2026, no new company-specific announcement was identified; the latest listed company release concerns conference data announced October 8.
- Prior-session coverage also described the move as consistent with biotech strength. No trading-volume information was provided.